Načítá se...
Neprilysin inhibition in chronic kidney disease
Despite current practice, patients with chronic kidney disease (CKD) are at increased risk of progression to end-stage renal disease and cardiovascular events. Neprilysin inhibition (NEPi) is a new therapeutic strategy with potential to improve outcomes for patients with CKD. NEPi enhances the activ...
Uloženo v:
| Vydáno v: | Nephrol Dial Transplant |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425478/ https://ncbi.nlm.nih.gov/pubmed/25140014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfu269 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|